Production (Stage)
Yubo International Biotech Limited
YBGJ
$0.0612
$0.015233.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.83M | -1.78M | -2.00M | -1.42M | -1.26M |
| Total Depreciation and Amortization | 181.40K | 183.30K | 256.00K | 254.70K | 227.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.00K | 5.50K | 73.00K | -272.60K | -32.20K |
| Change in Net Operating Assets | 37.00K | 38.70K | 500.60K | 358.00K | 24.10K |
| Cash from Operations | -1.61M | -1.55M | -1.17M | -1.08M | -1.04M |
| Capital Expenditure | 12.70K | 0.00 | 0.00 | 0.00 | -18.90K |
| Sale of Property, Plant, and Equipment | 118.50K | 118.50K | 118.50K | 82.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.10K | 0.00 | 0.00 | 0.00 | -11.10K |
| Cash from Investing | 142.30K | 118.50K | 118.50K | 82.00K | -30.00K |
| Total Debt Issued | 1.31M | 1.24M | 955.90K | 955.90K | 955.90K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 276.60K | 374.60K | 297.80K | 272.40K | 98.00K |
| Cash from Financing | 1.59M | 1.62M | 1.25M | 1.23M | 1.05M |
| Foreign Exchange rate Adjustments | -167.10K | -187.20K | -195.70K | -231.80K | 39.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.20K | 700.00 | 2.80K | 2.60K | 26.90K |